State Of Wyoming Novo Nordisk A S Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $1,032 - $1,218	-10 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$93.1 - $112.54 $186 - $225	-2 Reduced 16.67%	10 $1,000
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $191 - $234	-2 Reduced 14.29%	12 $1,000
Q3 2021 Feb 11, 2022	SELL	$84.42 - $106.62 $1,013 - $1,279	-12 Reduced 46.15%	14 $1,000
Q2 2021 Feb 11, 2022	BUY	$67.66 - $84.76 $947 - $1,186	14 Added 116.67%	26 $2,000
Q1 2021 Feb 08, 2022	BUY	$67.06 - $75.82 $804 - $909	12 New	12 $1,000

1,952

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $238B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.